Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2876-2883

  Murthy, Aditya ^a   Shao, Yang Washington ^a   Defamie, Virginie ^a   Wedeles, Christopher ^a   Smookler, David ^a   Khokha, Rama ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 10; INTERLEUKIN 17; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; GENE; GENETIC TRANSCRIPTION; LIVER CELL; LIVER PROTECTION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STROMA; T LYMPHOCYTE ACTIVATION; TH1 CELL; TIMP3 GENE;

ANIMALS; CELL SEPARATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEPATITIS, AUTOIMMUNE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84857850967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102199     Document Type: Article

References (45)

1. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27: 147-163.
2. Ichiki, Y., C. A. Aoki, C. L. Bowlus, S. Shimoda, H. Ishibashi, and M. E. Gershwin. 2005. T cell immunity in autoimmune hepatitis. Autoimmun. Rev. 4: 315-321. (Pubitemid 40884551)
3. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
4. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
5. Bonder, C. S., M. U. Norman, M. G. Swain, L. D. Zbytnuik, J. Yamanouchi, P. Santamaria, M. Ajuebor, M. Salmi, S. Jalkanen, and P. Kubes. 2005. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23: 153-163. (Pubitemid 41169285)
6. Erhardt, A., M. Biburger, T. Papadopoulos, and G. Tiegs. 2007. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45: 475-485. (Pubitemid 46374604)
7. Grivennikov, S. I., A. V. Tumanov, D. J. Liepinsh, A. A. Kruglov, B. I. Marakusha, A. N. Shakhov, T. Murakami, L. N. Drutskaya, I. Förster, B. E. Clausen, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22: 93-104. (Pubitemid 40143454)
8. Jiang, W., R. Sun, R. Zhou, H. Wei, and Z. Tian. 2009. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J. Immunol. 182: 3768-3774.
9. Murphy, G., A. Murthy, and R. Khokha. 2008. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol. 29: 75-82.
10. Consolo, M., A. Amoroso, D. A. Spandidos, and M. C. Mazzarino. 2009. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). [Review] Int. J. Mol. Med. 24: 143-152.
11. Menghini, R., S. Menini, R. Amoruso, L. Fiorentino, V. Casagrande, V. Marzano, F. Tornei, P. Bertucci, C. Iacobini, M. Serino, et al. 2009. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136: 663-672.e664.
12. Mohammed, F. F., D. S. Smookler, S. E. Taylor, B. Fingleton, Z. Kassiri, O. H. Sanchez, J. L. English, L. M. Matrisian, B. Au, W. C. Yeh, and R. Khokha. 2004. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 36: 969-977. (Pubitemid 39167493)
13. Murthy, A., V. Defamie, D.S. Smookler, M.A. Di Grappa, K. Horiuchi, M. Federici, M. Sibilia, C.P. Blobel, and R. Khokha 2010. Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J. Clin. Invest. 120: 2731-2744.
14. Smookler, D. S., F. F. Mohammed, Z. Kassiri, G. S. Duncan, T. W. Mak, and R. Khokha. 2006. Tissue inhibitor of metalloproteinase 3 regulates TNFdependent systemic inflammation. J. Immunol. 176: 721-725. (Pubitemid 43099666)
15. Liu, W., Y. Hou, H. Chen, H. Wei, W. Lin, J. Li, M. Zhang, F. He, and Y. Jiang. 2011. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 11: 3556-3564.
16. Boisvert, J., E. J. Kunkel, J. J. Campbell, E. B. Keeffe, E. C. Butcher, and H. B. Greenberg. 2003. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J. Hepatol. 38: 67-75. (Pubitemid 36078526)
17. Borland, G., G. Murphy, and A. Ager. 1999. Tissue inhibitor of metalloproteinases- 3 inhibits shedding of L-selectin from leukocytes. J. Biol. Chem. 274: 2810-2815. (Pubitemid 29075363)
18. Li, Y., J. Brazzell, A. Herrera, and B. Walcheck. 2006. ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding. Blood 108: 2275-2279. (Pubitemid 44497510)
19. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
20. Toyabe, S., S. Seki, T. Iiai, K. Takeda, K. Shirai, H. Watanabe, H. Hiraide, M. Uchiyama, and T. Abo. 1997. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159: 1537-1542. (Pubitemid 127484135)
21. Federici, M., M. L. Hribal, R. Menghini, H. Kanno, V. Marchetti, O. Porzio, S. W. Sunnarborg, S. Rizza, M. Serino, V. Cunsolo, et al. 2005. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J. Clin. Invest. 115: 3494-3505. (Pubitemid 43121837)
22. Das, M., G. Sabio, F. Jiang, M. Rincón, R. A. Flavell, and R. J. Davis. 2009. Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell 136: 249-260.
23. Jin, X., T. A. Zimmers, E. A. Perez, R. H. Pierce, Z. Zhang, and L. G. Koniaris. 2006. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 43: 474-484.
24. Klein, C., T. Wüstefeld, U. Assmus, T. Roskams, S. Rose-John, M. Můller, M. P. Manns, M. Ernst, and C. Trautwein. 2005. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J. Clin. Invest. 115: 860-869. (Pubitemid 40489390)
25. Durán, A., A. Rodriguez, P. Martin, M. Serrano, J. M. Flores, M. Leitges, M. T. Diaz-Meco, and J. Moscat. 2004. Crosstalk between PKCzeta and the IL4/ Stat6 pathway during T-cell-mediated hepatitis. EMBO J. 23: 4595-4605. (Pubitemid 39657859)
26. Deng, Z. B., Y. Liu, C. Liu, X. Xiang, J. Wang, Z. Cheng, S. V. Shah, S. Zhang, L. Zhang, X. Zhuang, et al. 2009. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50: 1412-1420.
27. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659. (Pubitemid 47615503)
28. Klein, I., J. C. Cornejo, N. K. Polakos, B. John, S. A. Wuensch, D. J. Topham, R. H. Pierce, and I. N. Crispe. 2007. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110: 4077-4085. (Pubitemid 350248465)
29. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62. (Pubitemid 37328699)
30. Echeverria, I., A. Pereboev, L. Silva, A. Zabaleta, J. I. Riezu-Boj, M. Bes, M. Cubero, F. Borras-Cuesta, J. J. Lasarte, J. I. Esteban, et al. 2011. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Hepatology 54: 28-37.
31. Palucka, K., J. Banchereau, and I. Mellman. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33: 464-478.
32. Das, A., M. Hoare, N. Davies, A. R. Lopes, C. Dunn, P. T. Kennedy, G. Alexander, H. Finney, A. Lawson, F. J. Plunkett, et al. 2008. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205: 2111-2124.
33. Raziorrouh, B., A. Ulsenheimer, W. Schraut, M. Heeg, P. Kurktschiev, R. Zachoval, M. C. Jung, R. Thimme, C. Neumann-Haefelin, S. Horster, et al. 2011. Inhibitory molecules that regulate expansion and restoration of HCVspecific CD4+ T cells in patients with chronic infection. Gastroenterology 141: 1422-1431.
34. Egen, J. G., A. G. Rothfuchs, C. G. Feng, M. A. Horwitz, A. Sher, and R. N. Germain. 2011. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34: 807-819.
35. Heydtmann, M., and D. H. Adams. 2009. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 49: 676-688.
36. Sahin, H., C. Trautwein, and H. E. Wasmuth. 2010. Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol 7: 682-690.
37. Casrouge, A., J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour, A. Vallet- Pichard, V. Mallet, E. Mottez, J. Mapes, A. Fontanet, et al. 2011. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest. 121: 308-317.
38. Leifeld, L., F. L. Dumoulin, I. Purr, K. Janberg, C. Trautwein, M. Wolff, M. P. Manns, T. Sauerbruch, and U. Spengler. 2003. Early up-regulation of chemokine expression in fulminant hepatic failure. J. Pathol. 199: 335-344. (Pubitemid 36266856)
39. Parks, W. C., C. L. Wilson, and Y. S. López-Boado. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4: 617-629. (Pubitemid 39025047)
40. Amend, B., H. Doster, C. Lange, E. Dubois, H. Kalbacher, A. Melms, and F. Bischof. 2006. Induction of autoimmunity by expansion of autoreactive CD4 +CD62Llow cells in vivo. J. Immunol. 177: 4384-4390. (Pubitemid 44469767)
41. Cauwels, A., B. Janssen, A. Waeytens, C. Cuvelier, and P. Brouckaert. 2003. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4: 387-393.
42. Hasselblatt, P., M. Rath, V. Komnenovic, K. Zatloukal, and E. F. Wagner. 2007. Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 104: 17105-17110.
43. Eksteen, B., S. C. Afford, S. J. Wigmore, A. P. Holt, and D. H. Adams. 2007. Immune-mediated liver injury. Semin. Liver Dis. 27: 351-366.
44. Dienes, H. P., and U. Drebber. 2010. Pathology of immune-mediated liver injury. Dig. Dis. 28: 57-62.
45. Roland, C. R., L. Walp, R. M. Stack, and M. W. Flye. 1994. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. J. Immunol. 153: 5453-5464. (Pubitemid 24377681)